No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy).
Intrastriatal injection of 3-nitropropionic acid results in secondary excitotoxic local damage and retrograde neuronal cell loss in substantia nigra pars compacta, thus mimicking salient features of striatonigral degeneration, the core pathology underlying Parkinsonism associated with multiple system atrophy. We used 3-nitropropionic acid to create a rat model of advanced striatonigral degeneration in order to assess the effects of embryonic allografts upon rotational and complex-motor behavioural abnormalities. Following stereotaxic intrastriatal administration of 500nmol 3-nitropropionic acid in male Wistar rats we observed consistent amphetamine- and apomorphine-induced ipsiversive rotation. Furthermore, there were marked deficits of contralateral paw reaching. Subsequently, animals received intrastriatal implantations of either E14 mesencephalic or striatal or mixed embryonic cell suspensions. In addition, one group received sham injections. Grafted rats were followed for up to 21 weeks and repeated behavioural tests were obtained during this period. Drug-induced rotation asymmetries and complex motor deficits measured by paw reaching tests were not compensated by embryonic grafts. Persistence of drug-induced rotations and of paw reaching deficits following transplantation probably reflects severe atrophy of adult striatum, additional nigral degeneration as well as glial demarcation of embryonic grafts. We suggest that dopamine rich embryonic grafts fail to induce functional recovery in a novel 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy).
Neurological Research Laboratory, Department of Neurology, University Hospital Innsbruck, Anichstrasse 35, A-6020, Innsbruck, Austria.
R
R
Waldner
Z
Z
Puschban
C
C
Scherfler
K
K
Seppi
K
K
Jellinger
W
W
Poewe
G K
GK
Wenning
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D016380:Brain Tissue Transplantation / Q000502:physiology*; D003342:Corpus Striatum / Q000473:pathology; D003913:Dextroamphetamine / Q000494:pharmacology; D004195:Disease Models, Animal; D016332:Fetal Tissue Transplantation / Q000502:physiology*; D006801:Humans; D008297:Male; D008636:Mesencephalon; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology*; D019578:Multiple System Atrophy / Q000473:pathology / Q000503:physiopathology* / Q000601:surgery*; D009474:Neurons / Q000473:pathology / Q000502:physiology* / Q000637:transplantation; D009498:Neurotoxins; D009574:Nitro Compounds; D011422:Propionates; D011597:Psychomotor Performance / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D013378:Substantia Nigra / Q000473:pathology; D013997:Time Factors
D009498:Neurotoxins; D009574:Nitro Compounds; D011422:Propionates; D001058:Apomorphine; C015392:3-nitropropionic acid; D003913:Dextroamphetamine